Clinical Trial of SARS-CoV-2 mRNA Vaccine in China

NCT05364047 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Low-dose of LVRNA009
BIOLOGICAL: Middle-dose of LVRNA009
BIOLOGICAL: High-dose of LVRNA009
OTHER: Placebo

Sponsor

AIM Vaccine Co., Ltd.

Collaborators

[object Object]
[object Object]